← Eichor
Condition: Chondrosarcoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chondrosarcoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing
Phase N/A · 1 location(s) · Eunice Kennedy Shriver National Institute of Child Health an · NCT06749366
Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
Phase N/A · 3 location(s) · Mayo Clinic · NCT05033288
Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas
Phase N/A · 2 location(s) · Leiden University Medical Center · NCT04832620
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treat
Phase 3 · 114 location(s) · Servier Bio-Innovation LLC · NCT06127407
Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma
Phase 2 · 7 location(s) · Italian Sarcoma Group · NCT04305548
Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base
NA · 1 location(s) · Quironsalud · NCT05861245
Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas
NA · 16 location(s) · Centre Leon Berard · NCT04055220
A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
NA · 3 location(s) · Ricoh USA, Inc. · NCT06387485
PET-imaging of Two Vartumabs in Patients With Solid Tumors
EARLY_Phase 1 · 1 location(s) · Var2 Pharmaceuticals · NCT06645808
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05039801
Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery
Phase N/A · 1 location(s) · Istituto Ortopedico Rizzoli · NCT05779670
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and S
Phase 1/Phase 2 · 7 location(s) · St. Jude Children's Research Hospital · NCT06239272
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
NA · 1 location(s) · Centre Antoine Lacassagne · NCT06029218
Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06176989
Proton or Photon RT for Retroperitoneal Sarcomas
Phase 1/Phase 2 · 10 location(s) · Massachusetts General Hospital · NCT01659203
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Phase 2 · 4 location(s) · Medical College of Wisconsin · NCT04040205
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
Phase N/A · 5 location(s) · Memorial Sloan Kettering Cancer Center · NCT03442465
Diagnostic and Therapeutic Targets in Cartilaginous Tumours
Phase N/A · 1 location(s) · St. Anne's University Hospital Brno, Czech Republic · NCT07315542
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.